Norah Conway

Norah Conway has over 20 years of experience in the pharmaceutical industry. Norah is currently serving as the Senior Vice President of Portfolio, Program, and Alliance Management at Alector. Prior to this, they held roles as the Vice President of Program Management & Development Program Leadership at Tranquis Therapeutics, Inc, and the Vice President of Program, Portfolio, and Alliance Management at Catalyst Biosciences.

Norah also worked at Ultragenyx Pharmaceutical Inc. as the Executive Director of Program and Portfolio Management. Before that, they held various positions at Bayer Pharmaceuticals, including Global Program Head and Global Project Leader. Early in their career, Norah served as the Director of Strategic Development Projects and the International Project Director at Bayer. Norah also held roles in International Regulatory Affairs, including Director and Deputy Director.

Throughout their career, Norah Conway has demonstrated expertise in program and portfolio management, alliance management, and regulatory affairs.

Norah Conway attended the University of Pretoria/Universiteit van Pretoria from 1987 to 1990. During this period, they pursued a degree in M.Pharm from the Faculty of Medicine.